% alzhub.org library filter
% Source: https://alzhub.org/research?institution=I154526488&atag=randomized
% 27 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{egan2019-30970186,
  author  = {Egan, M. F. and Kost, J. and Voss, T. and Mukai, Y. and Aisen, P. S. and Cummings, J. L. and Tariot, P. N. and Vellas, B. and others},
  title   = {{Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2019},
  doi     = {10.1056/nejmoa1812840},
  pmid    = {30970186},
  url     = {https://doi.org/10.1056/nejmoa1812840}
}

@article{buddhaeberlein2022-35542991,
  author  = {Budd Haeberlein, S. and Aisen, P. S. and Barkhof, F. and Chalkias, S. and Chen, T. and Cohen, S. and Dent, G. and Hansson, O. and others},
  title   = {{Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2022},
  doi     = {10.14283/jpad.2022.30},
  pmid    = {35542991},
  url     = {https://doi.org/10.14283/jpad.2022.30}
}

@article{egan2018-29719179,
  author  = {Egan, M. F. and Kost, J. and Tariot, P. N. and Aisen, P. S. and Cummings, J. L. and Vellas, B. and Sur, C. and Mukai, Y. and others},
  title   = {{Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2018},
  doi     = {10.1056/nejmoa1706441},
  pmid    = {29719179},
  url     = {https://doi.org/10.1056/nejmoa1706441}
}

@article{honig2018-29365294,
  author  = {Honig, L. S. and Vellas, B. and Woodward, M. and Boada, M. and Bullock, R. and Borrie, M. and Hager, K. and Andreasen, N. and others},
  title   = {{Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2018},
  doi     = {10.1056/nejmoa1705971},
  pmid    = {29365294},
  url     = {https://doi.org/10.1056/nejmoa1705971}
}

@article{vandyck2023-36449413,
  author  = {van Dyck, C. H. and Swanson, C. J. and Aisen, P. and Bateman, R. J. and Chen, C. and Gee, M. and Kanekiyo, M. and Li, D. and others},
  title   = {{Lecanemab in Early Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2023},
  doi     = {10.1056/nejmoa2212948},
  pmid    = {36449413},
  url     = {https://doi.org/10.1056/nejmoa2212948}
}

@article{wessels2020-31764959,
  author  = {Wessels, A. M. and Tariot, P. N. and Zimmer, J. A. and Selzler, K. J. and Bragg, S. M. and Andersen, S. W. and Landry, J. and Krull, J. H. and others},
  title   = {{Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials}},
  journal = {JAMA neurology},
  year    = {2020},
  doi     = {10.1001/jamaneurol.2019.3988},
  pmid    = {31764959},
  url     = {https://doi.org/10.1001/jamaneurol.2019.3988}
}

@article{dubois2023-36849969,
  author  = {Dubois, B. and López-Arrieta, J. and Lipschitz, S. and Doskas, T. and Spiru, L. and Moroz, S. and Venger, O. and Vermersch, P. and others},
  title   = {{Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial}},
  journal = {Alzheimer's research \& therapy},
  year    = {2023},
  doi     = {10.1186/s13195-023-01169-x},
  pmid    = {36849969},
  url     = {https://doi.org/10.1186/s13195-023-01169-x}
}

@article{truong2022-36096687,
  author  = {Truong, C. and Recto, C. and Lafont, C. and Canoui-Poitrine, F. and Belmin, J. B. and Lafuente-Lafuente, C.},
  title   = {{Effect of Cholinesterase Inhibitors on Mortality in Patients With Dementia: A Systematic Review of Randomized and Nonrandomized Trials}},
  journal = {Neurology},
  year    = {2022},
  doi     = {10.1212/wnl.0000000000201161},
  pmid    = {36096687},
  url     = {https://doi.org/10.1212/wnl.0000000000201161}
}

@article{dichgans2008-18296124,
  author  = {Dichgans, M. and Markus, H. S. and Salloway, S. and Verkkoniemi, A. and Moline, M. and Wang, Q. and Posner, H. and Chabriat, H. S.},
  title   = {{Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL}},
  journal = {The Lancet. Neurology},
  year    = {2008},
  doi     = {10.1016/s1474-4422(08)70046-2},
  pmid    = {18296124},
  url     = {https://doi.org/10.1016/s1474-4422(08)70046-2}
}

@article{sevigny2024-38745011,
  author  = {Sevigny, J. and Uspenskaya, O. and Heckman, L. D. and Wong, L. C. and Hatch, D. A. and Tewari, A. and Vandenberghe, R. and Irwin, D. J. and others},
  title   = {{Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results}},
  journal = {Nature medicine},
  year    = {2024},
  doi     = {10.1038/s41591-024-02973-0},
  pmid    = {38745011},
  url     = {https://doi.org/10.1038/s41591-024-02973-0}
}

@article{dubois2012-22915447,
  author  = {Dubois, B. and Tolosa, E. and Katzenschlager, R. and Emre, M. and Lees, A. J. and Schumann, G. and Pourcher, E. and Gray, J. and others},
  title   = {{Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study}},
  journal = {Movement disorders : official journal of the Movement Disorder Society},
  year    = {2012},
  doi     = {10.1002/mds.25098},
  pmid    = {22915447},
  url     = {https://doi.org/10.1002/mds.25098}
}

@article{rolland2019-31426362,
  author  = {Rolland, Y. and Barreto, P. S. and Maltais, M. and Guyonnet, S. and Cantet, C. and Andrieu, S. and Vellas, B.},
  title   = {{Effect of Long-Term Omega 3 Polyunsaturated Fatty Acid Supplementation with or without Multidomain Lifestyle Intervention on Muscle Strength in Older Adults: Secondary Analysis of the Multidomain Alzheimer Preventive Trial (MAPT)}},
  journal = {Nutrients},
  year    = {2019},
  doi     = {10.3390/nu11081931},
  pmid    = {31426362},
  url     = {https://doi.org/10.3390/nu11081931}
}

@article{billiotidegage2014-25208536,
  author  = {Billioti de Gage, S. and Moride, Y. and Ducruet, T. and Kurth, T. and Verdoux, H. and Tournier, M. and Pariente, A. and Bégaud, B.},
  title   = {{Benzodiazepine use and risk of Alzheimer's disease: case-control study}},
  journal = {BMJ (Clinical research ed.)},
  year    = {2014},
  doi     = {10.1136/bmj.g5205},
  pmid    = {25208536},
  url     = {https://doi.org/10.1136/bmj.g5205}
}

@article{rouch2015-25700645,
  author  = {Rouch, L. and Cestac, P. and Hanon, O. and Cool, C. and Helmer, C. and Bouhanick, B. and Chamontin, B. and Dartigues, J. F. and others},
  title   = {{Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms}},
  journal = {CNS drugs},
  year    = {2015},
  doi     = {10.1007/s40263-015-0230-6},
  pmid    = {25700645},
  url     = {https://doi.org/10.1007/s40263-015-0230-6}
}

@article{giudici2020-33036701,
  author  = {Giudici, K. V. and de Souto Barreto, P. and Beard, J. and Cantet, C. and Araujo de Carvalho, I. and Rolland, Y. and Vellas, B. and {MAPT DSA group}},
  title   = {{Effect of long-term omega-3 supplementation and a lifestyle multidomain intervention on intrinsic capacity among community-dwelling older adults: Secondary analysis of a randomized, placebo-controlled trial (MAPT study)}},
  journal = {Maturitas},
  year    = {2020},
  doi     = {10.1016/j.maturitas.2020.06.012},
  pmid    = {33036701},
  url     = {https://doi.org/10.1016/j.maturitas.2020.06.012}
}

@article{vellas2006-17101932,
  author  = {Vellas, B. and Andrieu, S. and Ousset, P. J. and Ouzid, M. and Mathiex-Fortunet, H. and {GuidAge Study Group}},
  title   = {{The GuidAge study: methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761 for prevention of Alzheimer disease in patients over 70 with a memory complaint}},
  journal = {Neurology},
  year    = {2006},
  doi     = {10.1212/wnl.67.9_suppl_3.s6},
  pmid    = {17101932},
  url     = {https://doi.org/10.1212/wnl.67.9_suppl_3.s6}
}

@article{bracco2023-37875856,
  author  = {Bracco, L. and Pinto-Carral, A. and Hillaert, L. and Mourey, F.},
  title   = {{Tango-therapy vs physical exercise in older people with dementia; a randomized controlled trial}},
  journal = {BMC geriatrics},
  year    = {2023},
  doi     = {10.1186/s12877-023-04342-x},
  pmid    = {37875856},
  url     = {https://doi.org/10.1186/s12877-023-04342-x}
}

@article{delrieu2023-37872582,
  author  = {Delrieu, J. and Vellas, B. and Guyonnet, S. and Cantet, C. and Ovod, V. and Li, Y. and Bollinger, J. and Bateman, R. and others},
  title   = {{Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trial}},
  journal = {Alzheimer's research \& therapy},
  year    = {2023},
  doi     = {10.1186/s13195-023-01325-3},
  pmid    = {37872582},
  url     = {https://doi.org/10.1186/s13195-023-01325-3}
}

@article{carrie2012-22499458,
  author  = {Carrié, I. and van Kan, G. A. and Gillette-Guyonnet, S. and Andrieu, S. and Dartigues, J. F. and Touchon, J. and Dantoine, T. and Rouaud, O. and others},
  title   = {{Recruitment strategies for preventive trials. The MAPT study (MultiDomain Alzheimer Preventive Trial)}},
  journal = {The journal of nutrition, health \& aging},
  year    = {2012},
  doi     = {10.1007/s12603-012-0046-8},
  pmid    = {22499458},
  url     = {https://doi.org/10.1007/s12603-012-0046-8}
}

@article{chhetri2018-29405230,
  author  = {Chhetri, J. K. and de Souto Barreto, P. and Cantet, C. and Cesari, M. and Coley, N. and Andrieu, S. and Vellas, B.},
  title   = {{Trajectory of the MAPT-PACC-Preclinical Alzheimer Cognitive Composite in the Placebo Group of a Randomized Control Trial: Results from the MAPT Study: Lessons for Further Trials}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2018},
  doi     = {10.14283/jpad.2017.21},
  pmid    = {29405230},
  url     = {https://doi.org/10.14283/jpad.2017.21}
}

@article{maltais2019-30817982,
  author  = {Maltais, M. and de Souto Barreto, P. and Pothier, K. and Cantet, C. and Andrieu, S. and Rolland, Y. and Vellas, B. and {MAPT/DSA Study Group}},
  title   = {{Lifestyle multidomain intervention, omega-3 supplementation, or both for reducing the risk of developing clinically relevant depressive symptoms in older adults with memory complaints? Secondary analysis from the MAPT trial}},
  journal = {Experimental gerontology},
  year    = {2019},
  doi     = {10.1016/j.exger.2019.02.010},
  pmid    = {30817982},
  url     = {https://doi.org/10.1016/j.exger.2019.02.010}
}

@article{orgogozo2003-12847155,
  author  = {Orgogozo, Jean Marc and Gilman, Sid and Dartigues, Jean‐François and Laurent, Bernard and Puel, Michèle and Kirby, Lachlan and Jouanny, P. and Dubois, Bruno and Eisner, L. and Flitman, Stephen S. and Michel, Bernard‐François and Boada, Merçé and Frank, Ana and Hock, C.},
  title   = {{Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization}},
  journal = {Neurology},
  year    = {2003},
  doi     = {10.1212/01.wnl.0000073623.84147.a8},
  pmid    = {12847155},
  url     = {https://doi.org/10.1212/01.wnl.0000073623.84147.a8}
}

@article{ollat2007-17675917,
  author  = {Ollat, H. and Laurent, B. and Bakchine, S. and Michel, B. F. and Touchon, J. and Dubois, B.},
  title   = {{[Effects of the association of sulbutiamine with an acetylcholinesterase inhibitor in early stage and moderate Alzheimer disease]}},
  journal = {L'Encephale},
  year    = {2007},
  doi     = {10.1016/s0013-7006(07)91552-3},
  pmid    = {17675917},
  url     = {https://doi.org/10.1016/s0013-7006(07)91552-3}
}

@article{gilletteguyonnet2009-19328438,
  author  = {Gillette-Guyonnet, S. and Andrieu, S. and Dantoine, T. and Dartigues, J. F. and Touchon, J. and Vellas, B. and {MAPT Study Group}},
  title   = {{Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2009},
  doi     = {10.1016/j.jalz.2009.01.008},
  pmid    = {19328438},
  url     = {https://doi.org/10.1016/j.jalz.2009.01.008}
}

@article{soto2015-25226218,
  author  = {Soto, M. and Andrieu, S. and Nourhashemi, F. and Ousset, P. J. and Ballard, C. and Robert, P. and Vellas, B. and Lyketsos, C. G. and others},
  title   = {{Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design}},
  journal = {International psychogeriatrics},
  year    = {2015},
  doi     = {10.1017/s1041610214001720},
  pmid    = {25226218},
  url     = {https://doi.org/10.1017/s1041610214001720}
}

@article{oules2012-22915123,
  author  = {Oulès, B. and Del Prete, D. and Greco, B. and Zhang, X. and Lauritzen, I. and Sevalle, J. and Moreno, S. and Paterlini-Bréchot, P. and others},
  title   = {{Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease}},
  journal = {The Journal of neuroscience : the official journal of the Society for Neuroscience},
  year    = {2012},
  doi     = {10.1523/jneurosci.0875-12.2012},
  pmid    = {22915123},
  url     = {https://doi.org/10.1523/jneurosci.0875-12.2012}
}

@article{jessen2025-40640062,
  author  = {Jessen, Frank and Arbizu, Javier and Boada, Merçé and Balasa, Mircea and Bennys, Karim and Boban, Marina and Bürger, Katharina and Chincarini, A. and others},
  title   = {{Comment by European Alzheimer’s Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer’ s disease}},
  journal = {The Journal of Prevention of Alzheimer s Disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100259},
  pmid    = {40640062},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100259}
}